Generate Biomedicines, Inc. (GENB)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
13. 56
-0.1
-0.7321%
$
1.75B Market Cap
- P/E Ratio
- Div Yield
343,700 Volume
- Eps
$ 13.66
Previous Close 
Want to track GENB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Generate Biomedicines, Inc. (GENB) Statistics
Valuation metrics
Market Cap 1.75B
Enterprise value 1.69B
Trailing P/E (ttm) -2.72
Forward P/E -
PEG ratio -0.03
Price/Sales (ttm) 54.5
Price/Book (mrq) -1.1
Enterprise Value/Revenue 52.84
Enterprise Value/EBITDA -8.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 422.16K
Average volume (90 days) 778.5K
Price summary
52-Week low 11
52-Week high 18.18
Beta -
50-Day moving average 15.15
200-Day moving average 13.2
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.37%
Operating margin -7.37%
Operational effectiveness
Return on assets -0.62%
Return on equity 0.39%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.64
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 4.42
Total debt (mrq) -
Total Debt/Equity (mrq) -0.11
Current ratio (mrq) 2.85%
Book value per share (mrq) -12.44
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
